SuperworthHarmony Biosciences market cap HRMY
Share price times shares outstanding: what the whole company sells for, since 2020.
- Today, Oct 23, 2026
- $2.1B
- Highest close in our data
- $3.6B
- Dec 2022
Harmony Biosciences is worth $2.1B at the close on Oct 23, 2026, at $36.13 a share.
That is up 21% over the last year and down 11% over five years.
Its highest close in our data was $3.6B in Dec 2022.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $2.1B | $1.5B | $2.5B | −4% |
| 2025 | $2.2B | $1.5B | $2.3B | +13% |
| 2024 | $2B | $1.6B | $2.2B | +3% |
| 2023 | $1.9B | $1.2B | $3.2B | −42% |
| 2022 | $3.3B | $2B | $3.6B | +31% |
| 2021 | $2.5B | $1.5B | $2.6B | +21% |
| 2020 | $2.1B | $2B | $2.7B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Harmony Biosciences' size, closest first, today.
| Company | Market cap |
|---|---|
| HRMYHarmony Biosciences | $2.1B |
| PBHPrestige Consumer Healthcare | $2.3B |
| ANIPANI Pharmaceuticals | $1.7B |
| NRIXNurix Therapeutics | $2.8B |
| PAHCPhibro Animal Health | $1.6B |
| ANABAnaptysbio | $1.5B |
| PCRXPacira BioSciences | $1.5B |
| OGNOrganon | $3.6B |
| OMEROmeros | $1.2B |
| LQDALiquidia | $3.8B |
| ARQTArcutis Biotherapeutics | $3.9B |
| Peer median | $2B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Harmony Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.